/Companies

Adze Biotechnology

Coral Gables, US · Founded 2018 · Delaware corporation

Find your way into Adze Biotechnology

Sign up to see every warm intro you have to Adze Biotechnology

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Adze Biotechnology team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

SH
Sidney HoppsDirector and President/CEO
KT
Kenneth TemplinDirector, Secretary and Treasurer/CFO
RS
Richard SchulerNamed on SEC filing
PG
Patrick G. Sage, IINamed on SEC filing

Board

BK
Brendan KennyBoard director
GR
Gabriel RavivBoard director
GP
G. Patrick Sage, IIBoard director

Reported raises · per SEC filings

Form D private placements

$9.8M disclosed across 2 rounds · 2019–2023

▶$6.2MraisedNov 2025 · 21 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Brendan KennyDirector
  • Sidney HoppsExecutive Officer, Director
  • Gabriel RavivDirector
  • G. Patrick Sage, IIDirector
Offering amount
$15M
Amount sold
$6.2M
Minimum investment
$25K
Proceeds to insiders
$300K
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$3.7MraisedMay 2022 · 19 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Richard SchulerDirector
  • Patrick G. Sage, IIDirector
  • Kenneth TemplinExecutive Officer, Director
  • Gabriel RavivDirector
  • Sidney HoppsExecutive Officer, Director
Offering amount
$3.7M
Amount sold
$3.7M
Minimum investment
$30K
Finders' fees
$140K
Proceeds to insiders
$175K
Placement agents
Stuart Cornew, Craig R. McWilliams
First sale
Dec 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Adze Biotechnology raised?
Adze Biotechnology has disclosed $9.8M raised across 2 rounds.
Where is Adze Biotechnology headquartered?
Adze Biotechnology is headquartered in Coral Gables, US.